BRPI0815372A2 - predictive marker for egfr inhibitor treatment - Google Patents
predictive marker for egfr inhibitor treatmentInfo
- Publication number
- BRPI0815372A2 BRPI0815372A2 BRPI0815372A BRPI0815372A BRPI0815372A2 BR PI0815372 A2 BRPI0815372 A2 BR PI0815372A2 BR PI0815372 A BRPI0815372 A BR PI0815372A BR PI0815372 A BRPI0815372 A BR PI0815372A BR PI0815372 A2 BRPI0815372 A2 BR PI0815372A2
- Authority
- BR
- Brazil
- Prior art keywords
- egfr inhibitor
- inhibitor treatment
- predictive marker
- predictive
- marker
- Prior art date
Links
- 229940121647 egfr inhibitor Drugs 0.000 title 1
- 239000003550 marker Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07114305 | 2007-08-14 | ||
| PCT/EP2008/006518 WO2009021679A1 (en) | 2007-08-14 | 2008-08-07 | Predictive marker for egfr inhibitor treamtent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0815372A2 true BRPI0815372A2 (en) | 2019-09-24 |
Family
ID=39789783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0815372A BRPI0815372A2 (en) | 2007-08-14 | 2008-08-07 | predictive marker for egfr inhibitor treatment |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP2176429A1 (en) |
| JP (1) | JP2010535520A (en) |
| KR (1) | KR20100037633A (en) |
| CN (1) | CN101802221A (en) |
| AU (1) | AU2008286412A1 (en) |
| BR (1) | BRPI0815372A2 (en) |
| CA (1) | CA2695318A1 (en) |
| MX (1) | MX2010001572A (en) |
| WO (1) | WO2009021679A1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5646249A (en) * | 1994-02-28 | 1997-07-08 | The United States Of America As Represented By The Department Of Health And Human Services | Isolation and characterization of a novel chaperone protein |
| WO2004111273A2 (en) * | 2003-05-30 | 2004-12-23 | Genomic Health, Inc. | Gene expression markers for response to egfr inhibitor drugs |
| KR101126560B1 (en) * | 2003-05-30 | 2012-04-05 | 도꾜 다이가꾸 | Process for predicting drug response |
-
2008
- 2008-08-07 BR BRPI0815372A patent/BRPI0815372A2/en not_active IP Right Cessation
- 2008-08-07 CA CA2695318A patent/CA2695318A1/en not_active Abandoned
- 2008-08-07 MX MX2010001572A patent/MX2010001572A/en not_active Application Discontinuation
- 2008-08-07 JP JP2010520467A patent/JP2010535520A/en active Pending
- 2008-08-07 WO PCT/EP2008/006518 patent/WO2009021679A1/en not_active Ceased
- 2008-08-07 AU AU2008286412A patent/AU2008286412A1/en not_active Abandoned
- 2008-08-07 EP EP08785424A patent/EP2176429A1/en not_active Ceased
- 2008-08-07 CN CN200880102973A patent/CN101802221A/en active Pending
- 2008-08-07 KR KR1020107003252A patent/KR20100037633A/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| MX2010001572A (en) | 2010-03-15 |
| CA2695318A1 (en) | 2009-02-19 |
| KR20100037633A (en) | 2010-04-09 |
| AU2008286412A1 (en) | 2009-02-19 |
| EP2176429A1 (en) | 2010-04-21 |
| JP2010535520A (en) | 2010-11-25 |
| WO2009021679A1 (en) | 2009-02-19 |
| CN101802221A (en) | 2010-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2017016I1 (en) | PROTEASOMY INHIBITORS | |
| BRPI0806898A2 (en) | Mek inhibitors | |
| BRPI0813002A2 (en) | predictive markers for ovarian cancer | |
| DK2041138T3 (en) | PYRROLTRIAZINKINASE INHIBITORS | |
| DK2024375T3 (en) | Cyclopropyl-condensed indolobenzazepine-HCV-NS5B inhibitors | |
| BRPI0821129A2 (en) | Methods for healing inhibition | |
| BRPI0812040A2 (en) | INDICATIONS FOR ANTI-IL-I-BETA THERAPY | |
| EP2177529A4 (en) | NEW DE-SECRETASE INHIBITOR | |
| BRPI0815415A2 (en) | PREDICTIVE MARKER FOR EGFR INHIBITOR TREATMENT | |
| BRPI0815545A2 (en) | PREDICTIVE MARKERS FOR TREATMENT WITH EGFR INHIBITORS | |
| ATE522533T1 (en) | PYRAZOLOPYRIMIDINONKINASE INHIBITOR | |
| BRPI0814257A2 (en) | predictive marker for egfr inhibitor treatment | |
| BRPI0817361A2 (en) | PREDICTIVE MARKER FOR EGFR INHIBITOR TREATMENT | |
| BRPI0814354A2 (en) | PREDICTIVE MARKER FOR EGFR INHIBITOR TREATMENT | |
| BRPI0815414A2 (en) | EGFR INHIBITOR TREATMENT MARKER | |
| BRPI0812105A2 (en) | NERAMEXAN FOR NISTAGM TREATMENT | |
| BRPI0715729A2 (en) | glyt-1 inhibitors | |
| BRPI0815546A2 (en) | PREDICTIVE MARKER FOR EGFR INHIBITOR TREATMENT | |
| ES2395881T9 (en) | Predictive marker for EGFR inhibitor treatment | |
| BRPI0815372A2 (en) | predictive marker for egfr inhibitor treatment | |
| ES1064044Y (en) | FOOTWEAR TEMPLATE | |
| FI20075320A0 (en) | New useful inhibitors | |
| ES1064720Y (en) | GUIDE FOR PERSIANA | |
| ES1067107Y (en) | TRAIN FOR FOOTWEAR | |
| ES1065835Y (en) | CAPETUZA FOR CETRERIA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |